Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Biomolecules ; 10(7)2020 07 14.
Article in English | MEDLINE | ID: mdl-32674325

ABSTRACT

Holigarna caustica (Dennst.) Oken is used by the tribes of Northeast India for the treatment of intestinal problems. Therefore, the present study was undertaken to investigate the active principles of this plant responsible for its anthelmintic activity, using bioassay-guided fractionation. An ethanol extract of H. caustica fruit was fractionated on a silica gel column, followed by HPLC, while nematicidal activity was followed throughout on Caenorhabditis (C.) elegans as a model organism. Our study constitutes the first nematicidal report for this plant. Bioassay-guided purification led to the isolation of one compound (IC50 = 0.4 µM) as the only active constituent in the most active fraction. The compound was identified as linoleic acid based on spectroscopic data (1H and 13C NMR and ESI-MS). No cytotoxicity was observed in the crude extract or in linoleic acid (up to 356 µM). The results support the use of H. caustica for the treatment of intestinal problems by traditional healers in India.


Subject(s)
Anacardiaceae/chemistry , Caenorhabditis elegans/drug effects , Linoleic Acid/pharmacology , Animals , Caenorhabditis elegans/physiology , Cell Fractionation , Chromatography, High Pressure Liquid , Inhibitory Concentration 50 , Linoleic Acid/isolation & purification , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Extracts/pharmacology
2.
J Ethnopharmacol ; 248: 112352, 2020 Feb 10.
Article in English | MEDLINE | ID: mdl-31676401

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Warburgia ugandensis Sprague subspecies ugandensis is a plant widely distributed in Eastern, Central and Southern Africa. In humans, it is used to treat respiratory infections, tooth aches, malaria, skin infections, venereal diseases, diarrhea, fevers and aches. AIM OF THE STUDY: This study aims to identify the bioactive compounds against clinically important biofilm-forming strains of Candida and staphylococci that are responsible for tissue and implanted device-related infections. METHODS: Using a bioassay-guided fractionation approach, hexane -, ethanol -, acetone - and water extracts from the leaves of W. ugandensis, their subsequent fractions and isolated compounds were tested against both developing and preformed 24 h-biofilms of Candida albicans SC5314, Candida glabrata BG2, Candida glabrata ATCC 2001, Staphylococcus epidermidis 1457 and Staphylococcus aureus USA 300 using microtiter susceptibility tests. Planktonic cells were also tested in parallel for comparison purposes. Confocal scanning laser microscopy was also used to visualize effects of isolated compounds on biofilm formation. RESULTS: Warburganal, polygodial and alpha-linolenic acid (ALA) were the major bioactive compounds isolated from the acetone extract of W. ugandensis. For both warburganal and polygodial, the biofilm inhibitory concentration that inhibits 50% of C. albicans developing biofilms (BIC50) was 4.5 ±â€¯1 and 10.8 ±â€¯5 µg/mL respectively. Against S. aureus developing biofilms, this value was 37.9 ±â€¯8 µg/mL and 25 µg/mL with warburganal and ALA respectively. Eradication of preformed 24 h biofilms was also observed. Interestingly, synergy between the sesquiterpenoids and azoles against developing C. albicans biofilms resulted in an approximately ten-fold decrease of the effective concentration required to completely inhibit growth of the biofilms by individual compounds. The hydroxyl group in position C-9 in warburganal was identified as essential for activity against staphylococcal biofilms. We also identified additional promising bioactive sesquiterpenoids; drimenol and drimendiol from the structure-activity relationship (SAR) studies. CONCLUSIONS: ALA and four sesquiterpenoids: polygodial, warburganal, drimenol and drimendiol, have shown biofilm-inhibitory activity that has not been reported before and is worth following up. These compounds are potential drug candidates to manage biofilm-based infections, possibly in combination with azoles.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antifungal Agents/pharmacology , Biofilms/drug effects , Candida/drug effects , Magnoliopsida , Plant Extracts/pharmacology , Plant Leaves , Staphylococcus/drug effects , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/isolation & purification , Antifungal Agents/chemistry , Antifungal Agents/isolation & purification , Biofilms/growth & development , Candida/growth & development , Magnoliopsida/chemistry , Molecular Structure , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Leaves/chemistry , Staphylococcus/growth & development , Structure-Activity Relationship
3.
Int J Antimicrob Agents ; 53(2): 128-136, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30063999

ABSTRACT

Human enterovirus 71 (EV-A71) infections cause a wide array of diseases ranging from diarrhoea and rashes to hand-foot-and-mouth disease and, in rare cases, severe neurological disorders. No specific antiviral drug therapy is currently available. Extracts from 75 Chinese medicinal plants selected for antiviral activity based on the Chinese pharmacopeia and advice from traditional Chinese medicine clinicians were tested for activity against EV-A71. The aqueous extract of the rhizome of Cimicifuga heracleifolia (Sheng Ma) and Arnebia euchroma (Zi Cao) showed potent antiviral activity. The active fractions were isolated by bioassay-guided purification, and identified by a combination of high-resolution mass spectrometry and nuclear magnetic resonance. Fukinolic acid and cimicifugic acid A and J, were identified as active anti-EV-A71 compounds for C. heracleifolia, whereas for A. euchroma, two caffeic acid derivatives were tentatively deduced. Commercially available fukinolic acid analogues such as L-chicoric acid and D-chicoric also showed in vitro micromolar activity against EV-A71 lab-strain and clinical isolates.


Subject(s)
Antiviral Agents/pharmacology , Boraginaceae/chemistry , Caffeic Acids/pharmacology , Cimicifuga/chemistry , Enterovirus A, Human/drug effects , Phenylacetates/pharmacology , Plant Extracts/pharmacology , Succinates/pharmacology , 3C Viral Proteases , Cysteine Endopeptidases , Enterovirus A, Human/isolation & purification , Enterovirus Infections/drug therapy , Enterovirus Infections/virology , Humans , Mass Spectrometry , Medicine, Chinese Traditional , Microbial Sensitivity Tests , Nuclear Magnetic Resonance, Biomolecular , Viral Proteins/antagonists & inhibitors , Virus Replication/drug effects
4.
Int J Parasitol ; 48(11): 833-844, 2018 09.
Article in English | MEDLINE | ID: mdl-30031002

ABSTRACT

Parasitic helminths continue to pose problems in human and veterinary medicine, as well as in agriculture. Resistance to current anthelmintics has prompted the search for new drugs. Anthelmintic metabolites from medicinal plants could be good anthelmintic drug candidates. However, the compounds active against nematodes have not been identified in most medicinal plants with anthelmintic activity. In this study, we aimed to identify the active compounds against helminths in Warburgia ugandensis Sprague subspecies ugandensis (Canellaceae) and study the underlying mechanism of action. A bioassay-guided isolation of anthelmintic compounds from the plant was performed using a Caenorhabditis elegans (C. elegans) test model with a WMicrotracker instrument to monitor motility. Three active compounds were purified and identified by nuclear magnetic resonance and high resolution MS: warburganal (IC50: 28.2 ±â€¯8.6 µM), polygodial (IC50: 13.1 ±â€¯5.3 µM) and alpha-linolenic acid (ALA, IC50: 70.1 ±â€¯17.5 µM). A checkerboard assay for warburganal and ALA as well as polygodial and ALA showed a fractional inhibitory concentration index of 0.41 and 0.37, respectively, suggesting that polygodial and ALA, as well as warburganal and ALA, have a synergistic effect against nematodes. A preliminary structure-activity relationship study for polygodial showed that the α,ß-unsaturated 1,4-dialdehyde structural motif is essential for the potent activity. None of a panel of C. elegans mutant strains, resistant against major anthelmintic drug classes, showed significant resistance to polygodial, implying that polygodial may block C. elegans motility through a mechanism which differs from that of currently marketed drugs. Further measurements showed that polygodial inhibits mitochondrial ATP synthesis of C. elegans in a dose-dependent manner (IC50: 1.8 ±â€¯1.0 µM). Therefore, we believe that the underlying mechanism of action of polygodial is probably inhibition of mitochondrial ATP synthesis. In conclusion, polygodial could be a promising anthelmintic drug candidate worth considering for further development.


Subject(s)
Anthelmintics/pharmacology , Biological Assay/methods , Caenorhabditis elegans/drug effects , Magnoliopsida/chemistry , Plant Extracts/chemistry , Sesquiterpenes/pharmacology , Animals , Anthelmintics/chemistry , Caenorhabditis elegans/ultrastructure , Cell Survival/drug effects , Dose-Response Relationship, Drug , HEK293 Cells , Humans , Inhibitory Concentration 50 , Mice , Molecular Structure , RAW 264.7 Cells , Sesquiterpenes/chemistry , Structure-Activity Relationship , alpha-Linolenic Acid/chemistry , alpha-Linolenic Acid/pharmacology
5.
Carbohydr Res ; 379: 1-6, 2013 Sep 20.
Article in English | MEDLINE | ID: mdl-23831634

ABSTRACT

The rare Mexican species Stevia phlebophylla A. Gray was long considered to be the only known Stevia species, beside the well-known S. rebaudiana, containing the highly sweet diterpenoid steviol glycosides. We report a re-evaluation of this claim after phytochemically screening leaves obtained from two herbarium specimens of S. phlebophylla for the presence of steviol glycosides. Despite extensive MS analyses, no steviol glycosides could be unambiguously verified. Instead, the main chromatographic peak eluting at retention times similar to those of steviol glycosides was identified as a new compound, namely 16ß-hydroxy-17-acetoxy-ent-kauran-19-oic acid-(6-O-ß-D-xylopyranosyl-ß-D-glucopyranosyl) ester (1) on the basis of extensive NMR and MS data as well as the characterization of its acid hydrolysate. Seven more compounds were detected by ESIMS which are possibly structurally related to 1. It can therefore be concluded that S. phlebophylla is unlikely to contain significant amounts of steviol glycosides, if any.


Subject(s)
Diterpenes/chemistry , Glycosides/chemistry , Plant Leaves/chemistry , Stevia/chemistry , Carbohydrate Conformation , Diterpenes/isolation & purification , Glycosides/isolation & purification , Magnetic Resonance Spectroscopy/standards , Reference Standards
SELECTION OF CITATIONS
SEARCH DETAIL
...